Skip to content

Evonik Industries
Search Search

Skip over generic navigation

  • www.evonik.com
  • Language
    • English
    • Deutsch

Skip over primary navigation

VESTOSINT® | HOMEVESTOSINT® | HOME
  • About VESTOSINT®About VESTOSINT®
  • Products & ServicesProducts & Services
  • Application AreasApplication Areas
  • ProcessingProcessing
  • ContactContact

Skip over visual

Skip over functional column



Skip over functional column

  • About VESTOSINT®
  • Quality & Approvals
  • Medical Technology

Medical technology

Directive 93/42/EEC applies to the use of materials in medical applications within the European Community. In August 1994 this directive was transposed into German law by passage of the Medizinproduktegesetz (Medical Devices Act). The pertinent national and international standards, such as ISO 10993 and DIN EN 30993-1, cover the details of the approval process. The current German Pharmacopoeia (DAB) and the European Pharmacopoeia can be used as supplementary regulatory works to make decisions in special cases. In case of doubt workpieces must be tested by the manufacturer or user under the conditions of use.

We would be happy to answer any further questions. Please get in touch with our regional contacts or our customer service center.

 

Overview

Quality & Approvals
  • Food Contact
  • Medical Technology
Environment & Safety
Downloads
  • Brochures
  • Professional Articles
  • Product Information
  • Press Releases
  • Certificates
Events & Fairs
Your Order

Overview

Coating Powders
  • Antimicrobial Powders
Fine Powders
Handling & Logistics
Application Technology

Overview

Coating of Metal
  • Wire Products
  • Water Management
  • Automotive
  • Other Parts
Coating Additives
  • Coil Coating
  • Textured Paints
  • Wood Paints
  • Packaging Foils
  • Rubber Surfaces
Thermoplastic Composites

Overview

Fluidized Bed Coating
Minicoating
Flame Spraying
Manufacturing composites
 
  • Downloads
  • Contact
  • Sitemap
  • Company information
  • Legal notice
  • Privacy policy
  • Print
  • Send this page